Gross, O. (2023). SGLT2 Inhibitors are Blockbusters in Adults - But Not Studied in Children with Kidney Disease due to Industry Conflicts of Commercial Interest: A Call for Help To Regulators. Medical Research Archives, 11(8). doi:10.18103/mra.v11i8.4383